About lab
One published Lab
Build with this Lab. Run it anywhere.
Use the same immutable release locally or through managed cloud execution, with its exact version and provenance preserved.
Preparing exact examples…
Orton2009 - Modelling cancerous mutations inthe EGFR/ERK pathway - EGF Model This model studies the aberrations inERK signalling for different cancer mutations. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.
Manifest
{
"io": {
"inputs": [
{
"name": "initial_free_egfreceptor",
"label": "FreeEGFReceptor",
"units": "native SBML value",
"default": 80000,
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.initial_free_egfreceptor",
"description": "Initial FreeEGFReceptor. Sets the initial value of bundled SBML symbol `species_1`."
},
{
"name": "initial_bound_egfreceptor",
"label": "BoundEGFReceptor",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.initial_bound_egfreceptor",
"description": "Initial BoundEGFReceptor. Sets the initial value of bundled SBML symbol `species_0`."
},
{
"name": "initial_degraded_egfreceptor",
"label": "DegradedEGFReceptor",
"units": "native SBML value",
"default": 0,
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.initial_degraded_egfreceptor",
"description": "Initial DegradedEGFReceptor. Sets the initial value of bundled SBML symbol `species_18`."
},
{
"name": "initial_ras_inactive",
"label": "RasInactive",
"units": "native SBML value",
"default": 120000,
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.initial_ras_inactive",
"description": "Initial RasInactive. Sets the initial value of bundled SBML symbol `species_5`."
},
{
"name": "initial_raf1_inactive",
"label": "Raf1Inactive",
"units": "native SBML value",
"default": 120000,
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.initial_raf1_inactive",
"description": "Initial Raf1Inactive. Sets the initial value of bundled SBML symbol `species_7`."
},
{
"name": "initial_erk_inactive",
"label": "ErkInactive",
"units": "native SBML value",
"default": 600000,
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.initial_erk_inactive",
"description": "Initial ErkInactive. Sets the initial value of bundled SBML symbol `species_11`."
}
],
"outputs": [
{
"name": "free_egfreceptor",
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.free_egfreceptor",
"description": "FreeEGFReceptor observable. Maps to SBML symbol `species_1`."
},
{
"name": "bound_egfreceptor",
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.bound_egfreceptor",
"description": "BoundEGFReceptor observable. Maps to SBML symbol `species_0`."
},
{
"name": "degraded_egfreceptor",
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.degraded_egfreceptor",
"description": "DegradedEGFReceptor observable. Maps to SBML symbol `species_18`."
},
{
"name": "ras_inactive",
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.ras_inactive",
"description": "RasInactive observable. Maps to SBML symbol `species_5`."
},
{
"name": "raf1_inactive",
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.raf1_inactive",
"description": "Raf1Inactive observable. Maps to SBML symbol `species_7`."
},
{
"name": "erk_inactive",
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.erk_inactive",
"description": "ErkInactive observable. Maps to SBML symbol `species_11`."
},
{
"name": "state",
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.state",
"description": "Full raw SBML observable record for reproducibility and downstream visualisation."
},
{
"name": "summary",
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.summary",
"description": "Change and peak summary across the simulated SBML observables."
},
{
"name": "species_labels",
"maps_to": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.species_labels",
"description": "Mapping from selected raw SBML observable symbols to display labels."
}
]
},
"tags": [
"biomodels_ebi",
"curated",
"drug-response",
"faithful",
"oncology",
"pharmacology",
"physiology",
"sbml",
"signal-transduction",
"signaling",
"systemsbiology",
"tumor-growth"
],
"title": "Orton2009 - Modelling cancerous mutations in the EGFR/ERK pathway - EGF Model Lab",
"models": [
{
"path": "models/core",
"alias": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model"
},
{
"path": "models/visualisation",
"alias": "visualisation"
}
],
"wiring": [
{
"to": [
"visualisation.oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model_state"
],
"from": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.state"
},
{
"to": [
"visualisation.oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model_summary"
],
"from": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.summary"
},
{
"to": [
"visualisation.oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model_species_labels"
],
"from": "oncology_sbml_orton2009_modelling_cancerous_mutations_in_the_e_biomd0000000623_model.species_labels"
}
],
"package": "orton2009-modelling-cancerous-mutations-in-the-egfr-erk-a60efba1",
"runtime": {
"duration": 10,
"initial_inputs": {},
"communication_step": 1
},
"version": "1.0.0",
"description": "Orton2009 - Modelling cancerous mutations inthe EGFR/ERK pathway - EGF Model This model studies the aberrations inERK signalling for different cancer mutations. It can be used to explore tumor-related dynamics and compare treatment-response behavior across conditions.",
"schema_version": "2.0"
}Runtime
Duration10
Comms Step1
Runs
Total0
Completed0
Failed0
Metadata
Packageorton2009-modelling-cancerous-mutations-in-the-egfr-erk-a60efba1
Created2026-05-16
Updated2026-06-13
biomodels_ebicurateddrug-responsefaithfuloncologypharmacologyphysiologysbmlsignal-transductionsignalingsystemsbiologytumor-growthvisualisationother